Anemia
📧 Sign up to get email alerts when something new happens for Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug [Phase 2]
A Phase 2 trial comparing epoetin alfa to placebo for persistent anemia resulting from cisplatin-based cancer therapy, assessing safety and …
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia [Phase 2]
This clinical trial update reports a Phase 2 study evaluating epoetin alfa for treating anemia caused by chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating epoetin alfa for the treatment of anemia in cancer patients receiving chemotherapy; study completed.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease [Phase 1]
Phase 1 trial to characterize the pharmacokinetic and pharmacodynamic profiles of epoetin alfa (PROCRIT) in anemic patients with chronic kid…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy [Phase 3]
Phase 3 trial evaluating epoetin alfa for anemia in cancer patients receiving non-platinum chemotherapy has completed. The study was sponsor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee. [Phase 3]
Phase 3 trial comparing epoetin alfa to placebo to facilitate presurgical autologous blood collection for spine, hip, or knee surgery; the s…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery. [Phase 3]
A Phase 3 study evaluated whether epoetin alfa reduces the need for blood transfusions around major orthopedic surgery; the trial has comple…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery. [Phase 3]
Phase 3 trial evaluated the effectiveness and safety of epoetin alfa during autologous blood donation before surgery. The study status is co…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy [Phase 2]
Phase 2 study comparing PROCRIT (epoetin alfa) 80,000 units every four weeks with 40,000 units every two weeks in cancer patients not receiv…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma [Phase 3]
This completed Phase 3 trial evaluated the effect of epoetin alfa on anemia in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery [Phase 2]
Phase 2 study evaluating epoetin alfa vs placebo to reduce blood transfusions and severe anemia around total hip replacement; study complete…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency [Phase 4]
Phase 4 trial evaluating early correction of anemia in patients with chronic kidney disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients [Phase 2]
Results from an extension Phase 2 study of the iron chelator deferasirox in patients with β-thalassemia and other rare chronic anemias have …
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Efficacy of Double Fortified Salt (DFS) to Improve Work Productivity in Women in India [NA]
This clinical trial update reports the completion of a study assessing whether double fortified salt improves work productivity in Indian wo…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy [Phase 3]
A Phase 3 trial evaluating a treatment for anemia in cancer patients not receiving chemotherapy or radiotherapy was terminated.
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy [Phase 3]
Phase 3 trial evaluating treatment for anemia in cancer patients not currently receiving chemotherapy or radiotherapy was terminated.
-
EMA withdrawal · 2011-04-19EMA Application withdrawn: Epostim (epoetin alfa) — Reliance GeneMedix Plc
The EMA entry for Epostim (epoetin alfa) shows that the application was withdrawn by Reliance GeneMedix Plc for the anemia indication.
-
CLINICAL_TRIALS withdrawal · 2011-04-19Clinical Trial Update: Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia [Phase 2]
A Phase 2 trial evaluating subcutaneous rilonacept for non-dialysis-dependent chronic kidney disease with anemia was withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer [Phase 3]
Phase 3 clinical trial evaluating darbepoetin alfa with or without iron for anemia caused by chemotherapy in cancer patients; the study is c…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients [Phase 3]
Phase 3 trial results evaluating extended dosing of PROCRIT (epoetin alfa) for maintaining hemoglobin in pre-dialysis chronic kidney disease…
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial [Phase 3]
An update on the RED-HF Phase 3 trial of darbepoetin alfa in heart failure shows an exploratory sub-study was conducted, and the trial has b…
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients [Phase 2]
Phase 2 trial update for iron sucrose in non-dialysis dependent pediatric CKD patients completed with posted results.
-
CLINICAL_TRIALS trial_result · 2011-03-17Clinical Trial Update: A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion [Phase 3]
A Phase 3 trial evaluating weekly epoetin alfa at two doses versus placebo in patients with low or intermediate-1 risk myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Restrictive and Liberal Transfusion Strategies in Intensive Care [NA]
A completed clinical trial comparing restrictive versus liberal blood transfusion strategies in intensive care units.
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Safety of Cotrimoxazole in HIV- and HAART-exposed Infants [Phase 4]
Phase 4 safety evaluation of cotrimoxazole (sulfamethoxazole-trimethoprim) in HIV- and HAART-exposed newborns has completed, noting safety e…